Free Trial

Moolec Science (MLEC) Competitors

Moolec Science logo
$0.85 -0.01 (-1.68%)
(As of 12/20/2024 05:31 PM ET)

MLEC vs. MNTN, GATE, ESHA, BMAC, SIEB, RCFA, PLAO, APXI, TCOA, and CFFS

Should you be buying Moolec Science stock or one of its competitors? The main competitors of Moolec Science include Everest Consolidator Acquisition (MNTN), Marblegate Acquisition (GATE), ESH Acquisition (ESHA), Black Mountain Acquisition (BMAC), Siebert Financial (SIEB), RCF Acquisition (RCFA), Patria Latin American Opportunity Acquisition (PLAO), APx Acquisition Corp. I (APXI), Zalatoris Acquisition (TCOA), and CF Acquisition Corp. VII (CFFS). These companies are all part of the "trading" industry.

Moolec Science vs.

Everest Consolidator Acquisition (NYSE:MNTN) and Moolec Science (NASDAQ:MLEC) are both small-cap unclassified companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, community ranking, risk, profitability, media sentiment, valuation and dividends.

Everest Consolidator Acquisition has a beta of 0.02, meaning that its stock price is 98% less volatile than the S&P 500. Comparatively, Moolec Science has a beta of -0.49, meaning that its stock price is 149% less volatile than the S&P 500.

Everest Consolidator Acquisition has higher earnings, but lower revenue than Moolec Science.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Everest Consolidator AcquisitionN/AN/AN/AN/AN/A
Moolec Science$5.63M5.81-$7.31M-$0.20-4.25

72.9% of Everest Consolidator Acquisition shares are owned by institutional investors. Comparatively, 0.1% of Moolec Science shares are owned by institutional investors. 60.3% of Everest Consolidator Acquisition shares are owned by insiders. Comparatively, 19.9% of Moolec Science shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Everest Consolidator Acquisition has a net margin of 0.00% compared to Moolec Science's net margin of -129.97%. Everest Consolidator Acquisition's return on equity of 0.00% beat Moolec Science's return on equity.

Company Net Margins Return on Equity Return on Assets
Everest Consolidator AcquisitionN/A N/A N/A
Moolec Science -129.97%-97.95%-27.91%

In the previous week, Everest Consolidator Acquisition's average media sentiment score of 0.00 equaled Moolec Science'saverage media sentiment score.

Company Overall Sentiment
Everest Consolidator Acquisition Neutral
Moolec Science Neutral

Moolec Science has a consensus price target of $6.00, suggesting a potential upside of 605.88%. Given Moolec Science's stronger consensus rating and higher probable upside, analysts plainly believe Moolec Science is more favorable than Everest Consolidator Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Everest Consolidator Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Moolec Science
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

Moolec Science received 3 more outperform votes than Everest Consolidator Acquisition when rated by MarketBeat users.

CompanyUnderperformOutperform
Everest Consolidator AcquisitionN/AN/A
Moolec ScienceOutperform Votes
3
100.00%
Underperform Votes
No Votes

Summary

Everest Consolidator Acquisition beats Moolec Science on 6 of the 11 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MLEC vs. The Competition

MetricMoolec ScienceHolding Offices IndustryStaples SectorNASDAQ Exchange
Market Cap$32.68M$418.99M$14.03B$9.07B
Dividend YieldN/A6.33%2.77%4.22%
P/E Ratio-4.252.5121.9617.19
Price / Sales5.81126.892.60116.80
Price / CashN/A61.1521.1437.86
Price / Book4.7284.165.854.78
Net Income-$7.31M$33.84M$572.90M$225.60M
7 Day Performance-1.16%9.37%-1.84%-1.24%
1 Month Performance-0.12%44.36%-3.05%3.36%
1 Year Performance-65.31%26.05%2.93%16.58%

Moolec Science Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MLEC
Moolec Science
1.6837 of 5 stars
$0.85
-1.7%
$6.00
+605.9%
-65.0%$32.68M$5.63M-4.254Positive News
Gap Down
MNTN
Everest Consolidator Acquisition
N/A$11.00
flat
N/AN/A$128.76MN/A0.002Positive News
GATE
Marblegate Acquisition
N/A$11.08
flat
N/A+4.6%$128.31MN/A0.003News Coverage
ESHA
ESH Acquisition
N/A$10.80
flat
N/A+5.8%$127.33MN/A0.00N/APositive News
BMAC
Black Mountain Acquisition
N/A$10.60
flat
N/AN/A$125.54MN/A0.002,021
SIEB
Siebert Financial
2.0185 of 5 stars
$3.10
-3.1%
N/A+79.8%$124.37M$71.51M12.31120Analyst Forecast
News Coverage
Gap Down
High Trading Volume
RCFA
RCF Acquisition
N/A$11.45
-0.4%
N/A+4.1%$120.57MN/A0.002,021
PLAO
Patria Latin American Opportunity Acquisition
N/A$11.63
flat
N/AN/A$119.67MN/A0.00N/APositive News
APXI
APx Acquisition Corp. I
N/A$12.03
+1.3%
N/A+6.5%$119.22MN/A0.00N/A
TCOA
Zalatoris Acquisition
N/A$11.07
flat
N/A-0.7%$118.12MN/A0.00N/A
CFFS
CF Acquisition Corp. VII
N/A$11.33
+0.3%
N/A+4.2%$116.47MN/A0.003

Related Companies and Tools


This page (NASDAQ:MLEC) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners